Paul-Sylvain Frenette, Albert Einstein College of Medicine, USA
Paul Frenette is the founding Director and Chair of the Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine at Albert Einstein College of Medicine. His research interests have concerned on the stem cell microenvironments in health and cancer, and the vascular biology in sickle cell disease. His laboratory has uncovered the critical role of the sympathetic nervous system in the regulation of hematopoietic stem cell (HSC) egress from their niches, in the pathogenesis of acute myeloid leukemia and prostate cancer. He also elucidated circadian rhythmicity in stem cell release from the bone marrow, and identified cellular constituents forming niches in the bone marrow. Dr. Frenette was elected member of the American Society for Clinical Investigation (2004) and of the Association of American Physicians (2010). He has served on several editorial and institutional boards, Scientific Committees of the American Society of Hematology, and multiple panels at the NIH. He served as President of the International Society of Experimental Hematology (ISEH) in 2015.
« Go Back